The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors

This publication has 11 references indexed in Scilit:

• The R-enantiomer of citalopram counteracts escitalopram-induced increase in extracellular 5-HT in the frontal cortex of freely moving rats
  Neuropharmacology, 2003
• R-citalopram counteracts the effect of escitalopram in a rat conditioned fear stress model of anxiety
  Pharmacology Biochemistry and Behavior, 2003
• R-citalopram attenuates anxiolytic effects of escitalopram in a rat ultrasonic vocalisation model
  European Journal of Pharmacology, 2003
• Pharmacological Characterization of N,N-Dimethyl-2-(2-amino-4-methylphenyl thio)benzylamine as a Ligand of the Serotonin Transporter with High Affinity and Selectivity
  The Journal of Pharmacology and Experimental Therapeutics, 2003
• Species‐scanning mutagenesis of the serotonin transporter reveals residues essential in selective, high‐affinity recognition of antidepressants
  Journal of Neurochemistry, 2001
• Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine
  Biological Psychiatry, 2001
• An Affinity‐Modulating Site on Neuronal Monoamine Transport Proteins
  Basic & Clinical Pharmacology & Toxicology, 1997
• The pharmacological effect of citalopram resides in the (S)-(+)-enantiomer
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1992
• Affinity modulation of [3H]imipramine, [3H]paroxetine and [3H]citalopram binding to the 5-HT transporter from brain and platelets
  European Journal of Pharmacology: Molecular Pharmacology, 1991
• Antidepressive drugs can change the affinity of [3H]imipramine and [3H]paroxetine binding to platelet and neuronal membranes
  European Journal of Pharmacology, 1985